We identified 276 patients with primary retroperitoneal WDLS and 353 patients with primary retroperitoneal DDLS who underwent resection between July 1982 and July 2021 at our institution. WDLS ...
A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas. This is an ASCO Meeting Abstract ...
High TMB and TAM density may predict positive ICI response in DDLPS patients, as shown in a case with pembrolizumab achieving pCR. The patient, initially treated with doxorubicin, pazopanib, and ...
Hosted on MSN
Fragmented care does not affect survival outcomes for retroperitoneal sarcoma, says research
Fragmented care—receiving medical treatment at more than one facility—has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as cancer ...
A new study further supports the use of radiotherapy in the treatment of retroperitoneal sarcoma. The finding comes from two large case-control analyses of 9068 patients with localized primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results